Reports / Gastroenterology Reports
Targeted biologics, the recent emergence of innovative new oral therapies and the arrival of biosimilars will continue to fuel monumental shifts in the way patients with auto-immune disorders are managed.
Rapid turnaround monitor for highly dynamic healthcare segments
Retrospective analysis of 1,000+/- patient charts
- Pre-Biologic Switching in Inflammatory Bowel Disease EU (coming 2019)
Learn more about our work in the gastroenterology space.